Los Angeles Capital Management’s Stoke Therapeutics STOK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$992K	Buy	30,479 +21,273	+231%	+$698K	﹤0.01%	686
2025 Q4	$292K	Sell	9,206 -57	-0.6%	-$1.71K	﹤0.01%	1115
2025 Q3	$218K	Sell	9,263 -10,452	-53%	-$179K	﹤0.01%	1246
2025 Q2	$224K	Buy	+19,715	New	+$187K	﹤0.01%	1151
2025 Q1	–	Sell	-43,438	Closed	-$479K	–	1219
2024 Q4	$479K	Sell	43,438 -59,567	-58%	-$732K	﹤0.01%	823
2024 Q3	$1.27M	Buy	103,005 +36,240	+54%	+$513K	0.01%	571
2024 Q2	$902K	Buy	66,765 +4,508	+7%	+$60.9K	﹤0.01%	686
2024 Q1	$840K	Hold	62,257	–	–	﹤0.01%	746
2023 Q4	$327K	Buy	62,257 +14,510	+30%	+$62K	﹤0.01%	990
2023 Q3	$188K	Sell	47,747 -1,330	-3%	-$8.75K	﹤0.01%	1073
2023 Q2	$522K	Buy	49,077 +10,022	+26%	+$107K	﹤0.01%	843
2023 Q1	$325K	Sell	39,055 -1,358	-3%	-$12.3K	﹤0.01%	988
2022 Q4	$373K	Buy	40,413 +12,190	+43%	+$127K	﹤0.01%	974
2022 Q3	$362K	Hold	28,223	–	–	﹤0.01%	1024
2022 Q2	$373K	Buy	28,223 +5,210	+23%	+$79.2K	﹤0.01%	1076
2022 Q1	$484K	Buy	23,013 +4,410	+24%	+$88.3K	﹤0.01%	1046
2021 Q4	$446K	Sell	18,603 -1,484	-7%	-$35.4K	﹤0.01%	1062
2021 Q3	$511K	Buy	20,087 +2,970	+17%	+$82.8K	﹤0.01%	1034
2021 Q2	$576K	Buy	+17,117	New	+$605K	﹤0.01%	1115

Other funds holding STOK